Radar-like MoS2 nanoparticles as a highly efficient 808 nm laser-induced photothermal agent for cancer therapy

Mitochondria are highly dynamic double-membrane organelles which play a well-recognized role in ATP production, calcium homeostasis, oxidation-reduction (redox) status, apoptotic cell death, and inflammation. Dysfunction of mitochondria has long been observed in a number of human diseases, including cancer. Targeting mitochondria metabolism in tumors as a cancer therapeutic strategy has attracted much attention for researchers in recent years due to the essential role of mitochondria in cancer cell growth, apoptosis, and progression. On the other hand, a series of studies have indicated that traditional medicinal herbs, including traditional Chinese medicines (TCM), exert their potential anticancer effects as an effective adjunct treatment for alleviating the systemic side effects of conventional cancer therapies, for reducing the risk of recurrence and cancer mortality and for improving the quality of patients’ life. An amazing feature of these structurally diverse bioactive components is that majority of them target mitochondria to provoke cancer cell-specific death program. The aim of this review is to summarize the in vitro and in vivo studies about the role of these herbs, especially their bioactive compounds in the modulation of the disturbed mitochondrial function for cancer therapy.

Download Full-text

Boosting Chemodynamic Therapy by the Synergistic Effect of Co-Catalyze and Photothermal Effect Triggered by the Second Near-Infrared Light

Nano-Micro Letters ◽

10.1007/s40820-020-00516-z ◽

2020 ◽

Vol 12 (1) ◽

Author(s):

Songtao Zhang ◽

Longhai Jin ◽

Jianhua Liu ◽

Yang Liu ◽

Tianqi Zhang ◽

...

Keyword(s):

Cancer Therapy ◽

Bovine Serum Albumin ◽

Synergistic Effect ◽

Bovine Serum ◽

Photothermal Therapy ◽

Near Infrared ◽

Infrared Light ◽

Photothermal Effect ◽

Reaction Efficiency

AbstractIn spite of the tumor microenvironments responsive cancer therapy based on Fenton reaction (i.e., chemodynamic therapy, CDT) has been attracted more attentions in recent years, the limited Fenton reaction efficiency is the important obstacle to further application in clinic. Herein, we synthesized novel FeO/MoS2 nanocomposites modified by bovine serum albumin (FeO/MoS2-BSA) with boosted Fenton reaction efficiency by the synergistic effect of co-catalyze and photothermal effect of MoS2 nanosheets triggered by the second near-infrared (NIR II) light. In the tumor microenvironments, the MoS2 nanosheets not only can accelerate the conversion of Fe3+ ions to Fe2+ ions by Mo4+ ions on their surface to improve Fenton reaction efficiency, but also endow FeO/MoS2-BSA with good photothermal performances for photothermal-enhanced CDT and photothermal therapy (PTT). Consequently, benefiting from the synergetic-enhanced CDT/PTT, the tumors are eradicated completely in vivo. This work provides innovative synergistic strategy for constructing nanocomposites for highly efficient CDT.

Download Full-text

Highly efficient cell-mediated gene transfer using non-viral vectors and FuGene™6: in vitro and in vivo studies

Cellular and Molecular Life Sciences ◽

10.1007/pl00000769 ◽

2000 ◽

Vol 57 (8) ◽

pp. 1326-1333 ◽

Cited By ~ 30

Author(s):

I. Hellgren* ◽

V. Drvota ◽

R. Pieper ◽

S. Enoksson ◽

P. Blomberg ◽

...

Keyword(s):

Gene Transfer ◽

Viral Vectors ◽

In Vivo Studies ◽

Highly Efficient

Download Full-text

Folate-Functionalized Mesoporous Hollow SnO2 Nanofibers as a Targeting Drug Carrier to Improve the Antitumor Effect of Paclitaxel for Liver Cancer Therapy

BioMed Research International ◽

10.1155/2018/8526190 ◽

2018 ◽

Vol 2018 ◽

pp. 1-11

Author(s):

Huiling Lv ◽

Chao Wu ◽

Xuan Liu ◽

Andi Bai ◽

Yue Cao ◽

...

Keyword(s):

Cancer Therapy ◽

Liver Cancer ◽

Drug Carrier ◽

In Vitro Release ◽

Hollow Structure ◽

Amorphous State ◽

Outer Diameter ◽

Drug Delivery Carrier

In this study, we prepared PTX-loaded mesoporous hollow SnO2 nanofibers conjugated with folic acid (SFNFP) for liver cancer therapy. According to SEM and TEM characterization, SFNF showed a mesoporous hollow structure. The average outer diameter was 200 nm, and the wall thickness was 50 nm. The DSC and XRD study showed that PTX in the channels of nanofibers was present in an amorphous state. The in vitro release experiments demonstrated that SFNF could efficiently improve the dissolution rate of PTX. Both in vitro cell experiments and in vivo antitumor experiments showed that SFNFP could efficiently inhibit the growth of liver cancer cells. Therefore, SFNF is a promising targeting antitumor drug delivery carrier.

Download Full-text

Numerical Investigation of Ferrofluid Preparation during In-Vitro Culture of Cancer Therapy for Magnetic Nanoparticle Hyperthermia

Sensors ◽

10.3390/s21165545 ◽

2021 ◽

Vol 21 (16) ◽

pp. 5545 ◽

Cited By ~ 1

Author(s):

Izaz Raouf ◽

Piotr Gas ◽

Heung Soo Kim

Keyword(s):

Numerical Model ◽

Cancer Therapy ◽

Magnetic Nanoparticle ◽

Research Work ◽

Thermal Response ◽

Linear Response Theory ◽

Novel Approach ◽

Magnetic Nanoparticle Hyperthermia

Recently, in-vitro studies of magnetic nanoparticle (MNP) hyperthermia have attracted significant attention because of the severity of this cancer therapy for in-vivo culture. Accurate temperature evaluation is one of the key challenges of MNP hyperthermia. Hence, numerical studies play a crucial role in evaluating the thermal behavior of ferrofluids. As a result, the optimum therapeutic conditions can be achieved. The presented research work aims to develop a comprehensive numerical model that directly correlates the MNP hyperthermia parameters to the thermal response of the in-vitro model using optimization through linear response theory (LRT). For that purpose, the ferrofluid solution is evaluated based on various parameters, and the temperature distribution of the system is estimated in space and time. Consequently, the optimum conditions for the ferrofluid preparation are estimated based on experimental and mathematical findings. The reliability of the presented model is evaluated via the correlation analysis between magnetic and calorimetric methods for the specific loss power (SLP) and intrinsic loss power (ILP) calculations. Besides, the presented numerical model is verified with our experimental setup. In summary, the proposed model offers a novel approach to investigate the thermal diffusion of a non-adiabatic ferrofluid sample intended for MNP hyperthermia in cancer treatment.

Download Full-text

Multifunctional Cyanine-Based Theranostic Probe for Cancer Imaging and Therapy

International Journal of Molecular Sciences ◽

10.3390/ijms222212214 ◽

2021 ◽

Vol 22 (22) ◽

pp. 12214

Author(s):

Cheng-Liang Peng ◽

Ying-Hsia Shih ◽

Ping-Fang Chiang ◽

Chun-Tang Chen ◽

Ming-Cheng Chang

Keyword(s):

Photothermal Therapy ◽

Radionuclide Therapy ◽

Nuclear Imaging ◽

Biological Evaluation ◽

Targeted Radionuclide Therapy ◽

Nir Fluorescence ◽

Tumor Accumulation ◽

Selective Accumulation

Cancer is one of the leading causes of death in the world. A cancer-targeted multifunctional probe labeled with the radionuclide has been developed to provide multi-modalities for NIR fluorescence and nuclear imaging (PET, SPECT), for photothermal therapy (PTT), and targeted radionuclide therapy of cancer. In this study, synthesis, characterization, in vitro, and in vivo biological evaluation of the cyanine-based probe (DOTA-NIR790) were demonstrated. The use of cyanine dyes for the selective accumulation of cancer cells were used to achieve the characteristics of tumor markers. Therefore, all kinds of organ tumors can be targeted for diagnosis and treatment. The DOTA-NIR790 labeled with lutetium-111 could detect original or metastatic tumors by using SPECT imaging and quantify tumor accumulation. The β-emission of 177Lu-DOTA-NIR790 can be used for targeted radionuclide therapy of tumors. The DOTA-NIR790 enabled imaging by NIR fluorescence and by nuclear imaging (SPECT) to monitor in real-time the tumor accumulation and the situation of cancer therapy, and to guide the surgery or the photothermal therapy of the tumor. The radionuclide-labeled heptamethine cyanine based probe (DOTA-NIR790) offers multifunctional modalities for imaging and therapies of cancer.

Download Full-text

Targeting Sphingolipids for Cancer Therapy

Frontiers in Oncology ◽

10.3389/fonc.2021.745092 ◽

2021 ◽

Vol 11 ◽

Author(s):

Osmel Companioni ◽

Cristina Mir ◽

Yoelsis Garcia-Mayea ◽

Matilde E. LLeonart

Keyword(s):

Clinical Trials ◽

Cell Death ◽

Cancer Therapy ◽

Preclinical Studies ◽

Hepatic Toxicity ◽

Multiple Cancers ◽

Extensive Class ◽

Effective Drugs

Sphingolipids are an extensive class of lipids with different functions in the cell, ranging from proliferation to cell death. Sphingolipids are modified in multiple cancers and are responsible for tumor proliferation, progression, and metastasis. Several inhibitors or activators of sphingolipid signaling, such as fenretinide, safingol, ABC294640, ceramide nanoliposomes (CNLs), SKI-II, α-galactosylceramide, fingolimod, and sonepcizumab, have been described. The objective of this review was to analyze the results from preclinical and clinical trials of these drugs for the treatment of cancer. Sphingolipid-targeting drugs have been tested alone or in combination with chemotherapy, exhibiting antitumor activity alone and in synergism with chemotherapy in vitro and in vivo. As a consequence of treatments, the most frequent mechanism of cell death is apoptosis, followed by autophagy. Aslthough all these drugs have produced good results in preclinical studies of multiple cancers, the outcomes of clinical trials have not been similar. The most effective drugs are fenretinide and α-galactosylceramide (α-GalCer). In contrast, minor adverse effects restricted to a few subjects and hepatic toxicity have been observed in clinical trials of ABC294640 and safingol, respectively. In the case of CNLs, SKI-II, fingolimod and sonepcizumab there are some limitations and absence of enough clinical studies to demonstrate a benefit. The effectiveness or lack of a major therapeutic effect of sphingolipid modulation by some drugs as a cancer therapy and other aspects related to their mechanism of action are discussed in this review.

Download Full-text